Novel STAR gene variant in a patient with classic lipoid congenital adrenal hyperplasia and combined pituitary hormone deficiency
- PMID: 33536409
- PMCID: PMC7859387
- DOI: 10.1038/s41439-021-00138-w
Novel STAR gene variant in a patient with classic lipoid congenital adrenal hyperplasia and combined pituitary hormone deficiency
Abstract
We report the first case of classic lipoid congenital adrenal hyperplasia and combined pituitary hormone deficiency. We identified pathogenic variants in the STAR gene: a novel variant of c.126_127delCCinsG, namely, p.Thr44Profs*2 and an already reported variant of c.634C>T, namely, p.Gln212*. The association with combined pituitary hormone deficiency might be just a coincidence.
Conflict of interest statement
Tomonobu Hasegawa has the following financial relationships to disclose: research funding from Novo Nordisk Pharma Ltd. and JCR Pharmaceuticals Co., Ltd.
Figures
References
-
- Bose, H. S., Sugawara, T., Strauss, J. F. III, Miller, W. L., Consortium ICLAH: International Congenital Lipoid Adrenal Hyperplasia Consortium. The pathophysiology and genetics of congenital lipoid adrenal hyperplasia. N. Engl. J. Med.335, 1870–1878 (1996). - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources